Tewfik H H, Buchsbaum H J, Latourette H B, Lifshitz S G, Tewfik F A
Int J Radiat Oncol Biol Phys. 1982 Jan;8(1):13-8. doi: 10.1016/0360-3016(82)90378-9.
From July 1970 to January 1977, 23 patients with previously untreated cancer of the cervix (CA CX), mostly Stage IIIB, were included in this study. The para-aortic lymph nodes (PALN) were histologically documented to have metastatic disease in all 23 patients. External radiation treatment (RT) was delivered using a Cobalt--60 machine to a spade-shaped field to treat the pelvic cavity and para-aortic area. The majority of the patients received 4000-6000 rad to the pelvic cavity and from 5000-5500 rad to the PALN's by external RT. In addition, intracavitary radium was used in 21 patients. Five patients are alive and free of disease at 115, 110, 90, 73 and 45 months after completion of RT. One survivor had clinical Stage IB, one had Stage IIB, and three had Stage IIIB cervical carcinoma. Two of 15 patients with clinically enlarged and suspicious para-aortic nodes are alive, while 3 of 8 patients with clinically normal appearing nodes survived. Three (60%) of the survivors developed late bowel radiation damage. Eighteen patients died--10 during the first year, 3 during the second year, 2 during the third year, 1 during the fourth year and 2 during the eighth year of the follow-up. Five (27.8%) of the patients who died had developed late bowel radiation damage. Fifteen of the 18 died with disease at an average of 21 months. Three patients died of intercurrent disease. Their average survival was 40 months, double that of patients dying of disease. This report suggests that in cancer of the cervix, radiation therapy can control some PALN metastatic disease, but the risk of complications is rather high. In the absence of better methods of management, this risk of complications is justifiable because the alternative is to leave known disease untreated.
1970年7月至1977年1月,本研究纳入了23例先前未经治疗的宫颈癌患者,多数为IIIB期。所有23例患者的腹主动脉旁淋巴结经组织学证实有转移病灶。采用钴 - 60机器进行体外放射治疗,照射范围为盆腔和腹主动脉旁区域的铲形野。大多数患者盆腔接受4000 - 6000拉德的照射剂量,腹主动脉旁淋巴结接受5000 - 5500拉德的体外放射剂量。此外,21例患者还接受了腔内镭疗。放疗结束后,5例患者分别在115、110、90、73和45个月时存活且无疾病。1例幸存者为临床IB期,1例为IIB期,3例为IIIB期宫颈癌。15例临床腹主动脉旁淋巴结肿大且可疑的患者中有2例存活,8例临床淋巴结外观正常的患者中有3例存活。3例(60%)幸存者出现了晚期肠道放射性损伤。18例患者死亡,随访的第一年有10例死亡,第二年3例,第三年2例,第四年1例,第八年2例。死亡的患者中有5例(27.8%)出现了晚期肠道放射性损伤。18例死亡患者中有15例死于疾病,平均病程21个月。3例患者死于并发疾病,他们的平均生存期为40个月,是死于疾病患者生存期的两倍。本报告表明,在宫颈癌中,放射治疗可控制部分腹主动脉旁淋巴结转移病灶,但并发症风险相当高。在没有更好治疗方法的情况下,这种并发症风险是合理的,因为否则已知的疾病将得不到治疗。